Efforts are underway to address obesity and reduce associated stigma. Various initiatives have been launched, including those supported by pharmaceutical companies such as Novo Nordisk and Boehringer Ingelheim, which are working to prioritize metabolic health and obesity in policy and advocacy. These initiatives are being implemented in different regions, including malaysia and singapore, with the goal of driving change and reshaping perceptions of obesity.